FAKTOR-OPTIONSSCHEIN - STRYKER CORP. Share Price

Certificat

DE000SD42J89

Real-time Boerse Frankfurt Warrants 15:29:57 17/06/2024 BST
4.16 EUR -0.24% Intraday chart for FAKTOR-OPTIONSSCHEIN - STRYKER CORP.
Current month+7.47%
1 month+28.31%
Date Price Change
17/06/24 4.16 -0.24%
14/06/24 4.17 +0.48%
13/06/24 4.15 -4.60%
12/06/24 4.35 +0.46%
11/06/24 4.33 -2.70%

Real-time Boerse Frankfurt Warrants

Last update June 17, 2024 at 03:29 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SD42J8
ISINDE000SD42J89
Date issued 29/03/2021
Strike 235.6 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.43
Lowest since issue 1.1
Spread 0.03
Spread %0.70%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
345 USD
Average target price
372.5 USD
Spread / Average Target
+7.98%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW